Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 673, pseudogene (RNU6-673P) is a member of the U6 small nuclear RNA pseudogene family in Homo sapiens. The U6 small nuclear RNA (U6 snRNA) is a core structural and catalytic RNA component of the spliceosome, the nuclear machinery responsible for excising introns from pre-messenger RNAs during splicing[1][3]. However, *RNU6-673P* itself is classified as a *pseudogene*, meaning it is a genomic sequence similar to a functional U6 snRNA gene but is generally regarded as nonfunctional and does not produce a functional RNA transcript[3]. Pseudogenes such as RNU6-673P typically arise due to gene duplication or retrotransposition events and may be nonfunctional due to mutations or a lack of regulatory elements needed for proper expression[2][3]. Vertebrate genomes often harbor numerous U6 snRNA pseudogenes, reflecting the high evolutionary conservation and importance of the parental U6 gene[3]. While most individual pseudogenes are not known to have specific biological functions, some pseudogenes in other gene families can act as miRNA decoys or regulatory non-coding RNAs, and emerging evidence suggests pseudogenes may sometimes play roles in gene regulation or disease, but there are no published or curated data supporting this for RNU6-673P[2]. RNU6-673P is **not considered a therapeutic target**, nor is it involved in pathways that are targets of currently approved drugs or biomarker strategies. No evidence indicates pathogenicity, actionable biology, or association with human disease for this specific pseudogene. Summary interpretation: RNU6-673P is a noncoding RNA pseudogene corresponding to the highly conserved U6 small nuclear RNA, with no established biological or therapeutic relevance. It is not a drug target, has no known interacting drugs or disease associations, and should not be classified as a target in pharmacological or biomarker contexts[3][2]. If clarification is needed or if this is a misidentification (e.g., confusion with the functional U6 snRNA or another RNU6 pseudogene), that should be taken into account, as the above applies specifically to the pseudogene RNU6-673P, not the active U6 snRNA or its protein partners.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 673, pseudogene (RNU6-673P).